C.M. Bidwell & Associates’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-234
Closed -$3K 241
2016
Q4
$3K Sell
234
-8,356
-97% -$107K ﹤0.01% 226
2016
Q3
$141K Buy
+8,590
New +$141K 0.03% 196